Quercetin prevents oxidative stress and NF-κB activation in gastric mucosa of portal hypertensive rats

Biochemical Pharmacology

Volumn 68, Issue 10, 2004, Pages 1939-1946

  Moreira, Andrea J ^a   Fraga, Christina ^b   Alonso, María ^c   Collado, Pilar S ^c   Zetller, Claudio ^b   Marroni, Claudio ^b   Marroni, Norma ^a   González Gallego, Javier ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Brasil   (Brazil)

^c UNIVERSITY OF LEÓN   (Spain)

Author keywords

Gastric mucosa; NF B; Nitric oxide; Oxidative stress; Portal hypertension; Quercetin

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; QUERCETIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFECT; EDEMA; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; STOMACH DISEASE; STOMACH MUCOSA; TISSUE SECTION; VASODILATATION; VEIN LIGATION;

EID: 5144222190     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.07.016     Document Type: Article

References (55)

1. E. Sikuler, D. Kravetz, and R.J. Groszmann Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model Am J Gastrointest Liver Physiol. 248 1985 G618 G625
2. S. Sakurabayashi, K.C. Koh, L. Chen, and R.J. Groszmann Octreotide ameliorates the increase in collateral blood flow during postprandial hyperemia in portal hypertensive rats J Hepatol. 36 2002 507 512
3. P.J. Thuluvath, and H.Y. Yoo Portal hypertensive gastropathy Am J Gastroenterol. 97 2002 2973 2978
4. T. Iwao, A. Toyonaga, K. Oho, T. Sakai, C. Tayama, and H. Masumoto Portal hypertensive gastropathy develops less in patients with cirrhosis and fundal varices J Hepatol. 26 1997 1235 1241
5. H. Kawanaka, M. Tomokawa, M.K. Joes, I.L. Szabo, R. Pai, and D. Baatar Defective mitogen-activated protein kinase (ERK2) signaling in gastric mucosa of portal hypertensive rats: potential therapeutics implications Hepatology 34 2001 990 999
6. J.M. Pique Portal hypertensive gastropathy Baillieres Clin Gastroenterol. 11 1997 257 270
7. B. Fernando, R. Marley, S. Holt, R. Anand, D. Harry, and P. Sanderson N-Acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rats Hepatology 28 1998 689 694
8. P.A. Cahill, E.M. Redmond, R. Hodges, S. Zhang, and J.V. Sitzman Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats J Hepatol. 25 1996 370 378
9. M. Ohta, S. Yamaguchi, N. Gotoh, and M. Tomikawa Pathogenesis of portal hypertensive gastropathy: a clinical and experimental review Surgery 131 2002 S165 S170
10. I. Villegas, M.J. Martín, C. La Casa, V. Motilva, and C. Alarcon de la Lastra Effects of oxicam inhibitors of ciclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study Free Radical Res 36 2002 769 777
11. R. Van den Berg, G.R. Haenen, H. Van den Berg, and A. Bast Transcription factor NF-κB as a potential biomarker for oxidative stress Br J Nutr. 86 2001 S121 S127
12. G.M. Hur, Y.S. Ryu, H.Y. Yun, B.H. Jeon, Y.M. Kim, and J.H. Seok Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-κB Biochem Biophys Res Commun. 261 1999 917 922
13. P. Vallance, and S. Moncada Hyperdinamic circulation in cirrhosis: a role for nitric oxide? Lancet 337 1991 776 778
14. A. Bomzon, and L.M. Blends The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis Hepatology 29 1994 1343 1350
15. C. Thiemermann, C. Szabo, J.A. Mitchell, and J.R. Vane Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide Proc Natl Acad Sci USA 90 1993 267 271
16. M.G.L. Hertog, and P.C. Hollman Potential health effects of the dietary flavonol quercetin Eur J Clin Nutr. 50 1996 63 71
17. B. Pawlikowska-Pawlega, W.I. Guszecki, L.E. Misiak, and A. Gawron The study of the quercetin action on human erythrocyte membranes Biochem Pharmacol. 66 2003 605 612
18. I. Huk, V. Brovkovich, V. Nanobash, G. Weigel, C. Neumayer, and L. Partyka Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study Br J Surg. 85 1998 1080 1085
19. M. Erden Inal, and A. Kahraman The protective effect of flavonol quercetin against ultraviolet A induced oxidative stress in rats Toxicology 154 2000 21 29
20. J. Duarte, M. Galisteo, M.A. Ocete, F. Pérez-Vizcaino, A. Zarzuelo, and J. Tamargo Effect of chronic quercetin treatment on hepatic oxidative status in spontaneously hypertensive rats Mol Cell Biochem. 221 2001 155 160
21. W. Peres, M.J. Tuón, S. Mato, P.S. Collado, N. Marroni, and J. González-Gallego Hepatoprotective effects of the flavonoid quercetin in rats with biliary obstruction J Hepatol. 33 2000 742 750
22. T.L. Wadsworth, and D.R. Koop Effects of Gingko biloba extract (Egb 761) and quercetin on lypopolysaccharide-induced release of nitric oxide Chem Biol Interact. 137 2001 43 58
23. K. Igura, T. Ohta, Y. Kuroda, and K. Kaji Resveratrol and quercetin inhibit angiogenesis in vitro Cancer Lett. 171 2001 11 16
24. K. Yang, S.A. Lamprecht, Y. Liu, H. Shinozaki, K. Fan, and D. Leung Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon Carcinogenesis 21 2000 1655 1660
25. J. Vorbioff, J.E. Bredfeldt, and R.J. Groszman Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension Am J Physiol. 244 1983 G52 G57
26. H.P. Misra, and I. Fridovich The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase J Biol Chem. 247 1972 3170 3175
27. J.A. Buege, and S.D. Aust Microsomal lipid peroxidation Methods Enzymol. 52 1978 302 309
28. B. González-Flecha, S. Llesuy, and A. Boveris Hydroperoxide- initiated Chemiluminescence: on assay for oxidative stress in biopsies of liver, heart, and muscle Free Radical Biol Med. 10 1991 41 47
29. N.A. Essani, G.M. McGuire, A.M. Manning, and H. Jaeschke Endotoxin-induced activation of the nuclear transcription factor NF-κB in hepatocytes. Kupffer cells and endothelial cells in vivo J. Immunol. 156 1996 2956
30. C.P. Tsui, J.J.Y. Sung, and F.W. Leing Role of acute elevation of portal venous pressure by exogenous glucagon on gastric mucosal injury in rats with portal hypertension Life Sci. 73 2003 1115 1129
31. N. Hilzenrat, A. Arish, A. Yaari, and E. Sikuler Acute hemodynamic changes following hemorrhage and volume restitution, using a low viscosity plasma expander, in anesthetized portal hypertensive rats J Hepatol. 31 1999 874 879
32. R. Sabra, and S. Shuman Influence of phenobarbital on changes in Na handling, hemodynamics and liver function due to portal vein ligation in rats Eur J Pharmacol. 413 2001 287 294
33. Y. Yokoyama, R. Baveja, N. Sonin, M.G. Clemens, and J.X. Zhang Hepatic neovascularization after partial portal vein ligation: novel mechanism of chronic regulation of blood flow Am J Physiol. 280 2001 G21 G31
34. Y. Bayraktar, F. Balkanci, B. Uzunalimoglu, A. Gozok, T. Koseoglu, and F. Batman Is portal hypertension due to liver cirrhosis a major factor in the development of portal hypertensive gastropathy? Am J Gastroenterol. 91 1996 554 558
35. C. Michiels, M. Raes, O. Toussaint, and J. Ramacle Importance of Se-glutathione peroxidase, catalase and Cu, Zn-SOD for cell survival against oxidative stress Free Radical Biol Med. 17 1994 235 248
36. T. Yoshikawa, Y. Naito, A. Kishi, T. Tomii, T. Kaneko, and S. Linuma Role of active oxygen, lipid peroxidation, and antioxidants in pathogenesis of gastric mucosal injury induced by indomethacin in rats Gut 34 1993 732 737
37. P. Cahill, C. Foster, C. Redmond, C. Gingalewski, Y. Wu, and J. Sitzmann Enhanced nitic oxide synthase activity in portal hypertensive rabbits Hepatology 22 1995 598 606
38. J. Claria, W. Jiménez, J. Claria, J. Ros, J. Martínez, and M. Bosch Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide Hepatology 15 1992 343 349
39. A. Gadano, P. Sogni, S. Yang, S. Cailmail, R. Moreau, and P. Nepveux Endothelial calcium-calmodulim dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats J Hepatol. 26 1997 678 686
40. P. Martin, D. Xu, M. Niederberger, A. Weigert, P. Tsai, and J. John Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats Am J Physiol. 270 1996 F494 F499
41. M. Niederberger, P. Gines, P. Martin, P. Tsai, K. Morris, and I. McMusrty Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats Hepatology 24 1996 947 951
42. S. Nadaud, M. Philippe, J. Arnal, J. Michel, and J. Soubrier Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow Circ Res. 79 1996 857 863
43. W. Sessa, K. Pritchard, N. Seyedi, J. Wang, and T. Hintze Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression Circ Res. 74 1994 349 353
44. Y.Y. Yang, H. Lin, Y.T. Huang, T.Y. Lee, M.C. Hou, and F.Y. Lee Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension J Hepatol. 36 2002 600 606
45. J.S. Hsieh, J.Y. Wang, S.R. Lin, S.T. Lian, F.M. Chen, and M.C. Hsieh Overexpression of inducible nitric oxide synthase in gastric mucosa of rats with portal hypertension: correlation with gastric mucosal damage J Surg Res. 115 2003 24 32
46. L. Liaudet, F. García-Soriano, and C. Szabo Biology of nitric oxide signaling Crit Care Med. 28 2000 N37 N52
47. S.J. Brand, Z. Morise, S. Tagerud, L. Mazzola, D.N. Granger, and M.B. Gisham Role of the proteasome in rat indomethacin-induced gastropathy Gastroenterology 116 1999 865 873
48. I.M. Verma, and J. Stevenson IkappaB kinase: beginning, not the end Proc Natl Acad Sci USA 94 1997 11758 11760
49. T.Z. Liu, C.C. Hu, C. Andrew, Y. Chen, A. Stern, and J.T. Cheng Differentiation status modulates transcription factor NF-κB activity in unstimulated human hepatocellular carcinoma cell lines Cancer Letts. 151 2000 49 56
50. K. Muraoka, K. Shimizu, X. Sun, T. Tani, R. Izumi, and K. Miwa Flavonoids exert diverse inhibitory effects on the activation of NF-κB Trasplant Proc. 34 2002 1335 1340
51. S.Y. Cho, S.J. Park, M.J. Kwon, T.S. Jeong, S.H. Bok, and W.Y. Choi Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage Mol Cell Biochem. 243 2003 153 160
52. E.R. Rimm, M.B. Katan, A. Ascherio, M. Stampfer, and W. Willet Relation between intake of flavonoids and risk for coronary heart disease in male health professionals Ann Intern Med. 125 1996 384 389
53. M. Ibarra, L. Moreno, R. Vera, A. Cogolludo, J. Duarte, and J. Tamargo Effects of the flavonoid quercetin and its methylated metabolite isorhamnetin in isolated arteries from spontaneous hypertensive rats Planta Med. 69 2003 995 1000
54. M.M. Mu, D. Chakravortty, T. Sugiyama, N. Koide, K. Takahashi, and I. Mori The inhibitory action of quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells J End Res. 7 2001 431 438
55. N. Li, and M. Karin Is NF-κB the sensor of oxidative stress? FASEB J 13 1999 1137 1143